Loading clinical trials...
Loading clinical trials...
An Open-Label Extension Study of Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis
The purpose of this open-label extension (OLE) study is to evaluate the safety and efficacy of etrasimod in participants with moderately to severely active ulcerative colitis (UC) who previously received double-blind treatment (either etrasimod 2 mg per day or placebo) during participation in one of the qualified Phase 3 or Phase 2 double-blind, placebo-controlled parent studies including but not limited to: (APD334-301 \[NCT03945188\] or APD334-302 \[NCT03996369\] or APD334-210 \[NCT04607837\]).
Age
16 - 80 years
Sex
ALL
Healthy Volunteers
No
Center for Digestive Health (Colonoscopy Location)
Dothan, Alabama, United States
Pulmonary Associates (Secondary PFT Location)
Dothan, Alabama, United States
Gut P.C., dba Digestive Health Specialists of the Southeast (IP Address)
Dothan, Alabama, United States
Inland Pulmonary Specialists [PFT Only]
Lake Elsinore, California, United States
A V Pediatrics,Allergy and Family Medicine
Lancaster, California, United States
Advanced Endoscopy and Pain Center(Colonoscopy)
Lancaster, California, United States
Antelope Valley Eye Care(Ophthalmologist)
Lancaster, California, United States
Jatinder S.Pruthi,MD FACG CPI
Lancaster, California, United States
Om Research LLC
Lancaster, California, United States
Renaissance Imaging Center(Chest X-Ray only)
Lancaster, California, United States
Start Date
September 5, 2019
Primary Completion Date
June 19, 2029
Completion Date
June 19, 2029
Last Updated
December 18, 2025
896
ACTUAL participants
Etrasimod
DRUG
Lead Sponsor
Pfizer
Collaborators
NCT07271069
NCT06975722
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07185009